DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The complicated schedules for administering topical steroid eye drops combined with
forgetfulness and physical difficulties instilling the drops may compromise compliance; which
in turn could increase the risk for secondary complications such as PME post-cataract
surgery, especially in a high-risk diabetic population. Dextenza, a sustained- release
steroid insert, could help preclude adherence difficulties and provide better
bioavailability, being as effective as, or more effective than steroid drops in preventing
PME. The aim of this study is to assess the incidence of PME in diabetic patients undergoing
cataract surgery when comparing the Dextenza insert to topical prednisolone acetate 1% drops.